Comparison of once-daily versus twice-daily combination antiretroviral therapy in treatment-naive patients: results of AIDS clinical trials group
(ACTG) A5073, a 48-week randomized controlled trial.
Prolonged evaluation of protocol 019 of the AIDS Clinical Trials Group
A study conducted by NIAID's Pediatric AIDS Clinical Trials Group
demonstrated that AZT, given to HIV-infected pregnant women who had very little or no prior antiretroviral therapy and CD4+ T cell counts above 200/[mm.
Partners and collaborators include Ichor Medical Systems, the Galveston National Laboratory, Yale University, the Institute of Human Virology,the Center for HIV/AIDS Vaccine Immunology, the National Cancer Institute, the NIH Division of AIDS, the Bill and Melinda Gates Foundation, the International AIDS Vaccine Initiative, the HIV Vaccines Trials Network, and the AIDS Clinical Trials Group
To assess the public health burden of coinfection in this population, he and his colleagues analyzed data from the National Institutes of Health--sponsored AIDS Clinical Trials Group
(ACTG) Longitudinal Linked Randomized Trials cohort.
1) This finding from an AIDS Clinical Trials Group
(ACTG) study underlines the danger of interrupting antiretrovirals--especially nonnucleosides--unless your doctor recommends and plans the interruption.
treatment-experienced patients is being conducted by the NIH-sponsored AIDS Clinical Trials Group
(ACTG) and is fully enrolled.
He also served as Community Constituency Representative to the American Foundation for AIDS Research (amfAR) and the AIDS Clinical Trials Group
The nationwide study is sponsored by the National Heart, Lung and Blood Institute (NHLBI), part of the National Institutes of Health (NIH), with additional resources and collaboration from the National Institute of Allergy and Infectious Diseases (NIAID) and the AIDS Clinical Trials Group
Swindells cautioned that her study--which was conducted under the auspices of the AIDS Clinical Trials Group
(a clinical trials organization funded by the National Institutes of Health) and was supported by grants from the NIH, Bristol-Myers Squibb Co.
In mid-March, 2003 the NIH suspended part of a two-year government sponsored AIDS CLINICAL TRIALS GROUP
STUDY (ACTG 5095) comparing AZT+3TC+abacavir (the components of Trizivir) to other regimens (Trizivir+Sustiva and Trizivir+Combivir) when it quickly found that the Trizivir combination alone does not protect patients as well as some of the other combinations of medicines.
Before 1995, primarily the Adult AIDS Clinical Trials Group
(AACTG) conducted multicenter AIDS-related cancer trials.